Oscar Health, Inc. (OSCR) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OSCR Revenue Growth
OSCR Revenue Analysis (2019–2025)
As of May 6, 2026, Oscar Health, Inc. (OSCR) generated trailing twelve-month (TTM) revenue of $11.70 billion, reflecting strong growth of +17.2% year-over-year. The most recent quarter (Q4 2025) recorded $2.81 billion in revenue, down 6.1% sequentially.
Looking at the longer-term picture, OSCR's 5-year compound annual growth rate (CAGR) stands at +81.8%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $11.70 billion in 2025, representing a new all-time high.
When compared to Healthcare sector peers including CLOV (+40.3% YoY), ALHC (+41.8% YoY), and ACGL (+14.3% YoY), OSCR has underperformed the peer group in terms of revenue growth. Compare OSCR vs CLOV →
OSCR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OSCRCurrent | $11.7B | +17.2% | +81.8% | -3.4% | |
 CLOV | $1.9B | +40.3% | +23.4% | -4.4% | |
 ALHC | $3.9B | +41.8% | +32.7% | 0.4% | |
 ACGL | $19.9B | +14.3% | +19.2% | 25.0% |
OSCR Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $11.70B | +27.5% | $1.68B | 14.4% | $-396,357,000 | -3.4% |
| 2024 | $9.18B | +56.5% | $9.18B | 100.0% | $33.4M | 0.4% |
| 2023 | $5.86B | +42.1% | $5.86B | 100.0% | $-267,300,000 | -4.6% |
| 2022 | $4.13B | +114.8% | $4.13B | 100.0% | $-610,075,000 | -14.8% |
| 2021 | $1.92B | +225.8% | $1.92B | 100.0% | $-570,580,000 | -29.7% |
| 2020 | $589.6M | +6.5% | $589.6M | 100.0% | $-405,780,000 | -68.8% |
| 2019 | $553.8M | - | $553.8M | 100.0% | $-259,389,000 | -46.8% |
See OSCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OSCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OSCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOSCR — Frequently Asked Questions
Quick answers to the most common questions about buying OSCR stock.
Is OSCR's revenue growth accelerating or slowing?
OSCR revenue is accelerating at +17.2% year-over-year, exceeding the 5-year CAGR of +81.8%. TTM revenue reached $11.7B. Growth momentum has increased versus prior periods.
What is OSCR's long-term revenue growth rate?
Oscar Health, Inc.'s 5-year revenue CAGR of +81.8% reflects the sustained expansion pattern. Current YoY growth of +17.2% is above this long-term average.
How is OSCR's revenue distributed by segment?
OSCR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.